Although the CD34+ subfraction of stem cells does not uniquely represent the subpopulation of quiescent stem cells, no significant differences were found in PTCH1 expression between CD34+ and CD34– populations derived from bone marrow CML samples [44]. This evidence concerns the gene PTCH1 and chronic myelogenous leukemia, BCR-ABL1 positive.